Ronald Locke, MD
Surgery · Fort Mill, SCNPI 1528065406
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (42.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 75.5% of it on its own, with 31 other manufacturers making up the rest. Among surgery clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $346.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$34K
- Boston Scientific$7K
- Silk Road Medical, Inc.$1K
- Bard Peripheral Vascular, Inc.$722
- Organogenesis Inc.$398
- Johnson & Johnson$332
- plus $1K from 26 others
What the payments were for
- Speaking & faculty fees$1130%
- Travel & lodging$5,62513%
- Food & beverage$5,37612%
- Education$14,40032%
- Other$19,20043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 9 | $33,767 |
| Boston Scientific | 36 | $6,999 |
| Silk Road Medical, Inc. | 9 | $1,457 |
| Bard Peripheral Vascular, Inc. | 12 | $722 |
| Organogenesis Inc. | 12 | $398 |
| Johnson & Johnson | 12 | $332 |
| Polarityte, Inc. | 5 | $125 |
| Penumbra, Inc. | 1 | $99 |
| Medtronic | 1 | $80 |
| Neuros Medical, Inc. | 3 | $59 |
| Davol Inc. | 1 | $59 |
| Boehringer Ingelheim | 3 | $59 |
| Stryker | 2 | $53 |
| Inari Medical, Inc. | 1 | $47 |
| Kerecis Limited | 3 | $44 |
| BD | 1 | $38 |
| OVIK Health, LLC | 1 | $36 |
| GSK | 2 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $33 |
| KCI USA, Inc. | 2 | $30 |
| Solventum Corporation | 1 | $30 |
| Cardiovascular Systems Inc. | 1 | $28 |
| Baxter Healthcare | 1 | $26 |
| Cashflow Solutions, LLC | 1 | $22 |
| Canon Medical Systems USA, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $20 |
| Sanara Medtech Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Leica Microsystems Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Advanced Respiratory, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$24,000
- EVLT$9,600
- ANGIOJET$3,292
- ENROUTE Transcarotid Neuroprotection System$2,646
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,323
- ENROUTE Transcarotid Stent$1,323
- VENOVO$472
- AngioJet Ultra 5000A$275
- XARELTO$125
- Puraply Antimicrobial$125
- GENERAL VASCULAR INTERVENTION$116
- Apligraf$113
- Dermagraft$113
- Puraply/Affinity/NuTech$113
- EKOSONIC$105
How this compares
$44,714 in reported general payments places this provider in the 95th percentile of 553 surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 218 | $201,746 |
| EliquisApixaban | 14 | $8,534 |
| BrilintaTicagrelor | 11 | $5,745 |
| SantylCollagenase Clostridium Hist. | 11 | $4,405 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 81 | $838 |
| Clindamycin Hcl | 18 | $139 |
| Tramadol Hcl | 17 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $332 | $201,746218 claims |
| AstraZenecaBrilinta | $17 | $5,74511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 553 surgery providers in South Carolina.
Other surgery in Fort Mill
- Ari KramerSpartanburg$502K
- Chitharanjan PullattranaCharleston$408K
- John ScottGreenville$242K
- Jason CundiffGreenville$235K
- Steven KahnCharleston$197K
- John KramerPawleys Island$194K
- William CobbGreenville$159K
- Steven LauzonSumter$143K
- Shanu KothariGreenville$122K
- Charles MitchellMoncks Corner$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.